ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.

Siqing Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.